Xeris Biopharma Holdings, Inc. (XERS) Current Ratio % [USD] 2022 - 2024

Historical data

Taxonomy & unit: ratio: %
Description: The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary: Xeris Biopharma Holdings, Inc. quarterly Current Ratio history and growth rate from 2022 to 2024.
Xeris Biopharma Holdings, Inc. Current Ratio for the quarter ending March 31, 2024 was 192 %, a 16.5% decline year-over-year.

Current Ratio, Quarterly (% [USD])

Current Ratio, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q1 2024	192	-37.9	-16.5%	Mar 31, 2024
Q4 2023	185	-61.8	-25%	Dec 31, 2023
Q3 2023	207	-19.2	-8.48%	Sep 30, 2023
Q2 2023	217	-28.2	-11.5%	Jun 30, 2023
Q1 2023	230			Mar 31, 2023
Q4 2022	247			Dec 31, 2022
Q3 2022	226			Sep 30, 2022
Q2 2022	245			Jun 30, 2022

* An asterisk sign (*) next to the value indicates that the value is likely invalid.